Our Technology
Why This Matters
Many cancers and hard-to-treat conditions originate in anatomical areas that are difficult to reach safely. Today, treatment options often rely on highly invasive surgery or systemic therapies that affect healthy tissue and are suitable for only a small subset of patients.
Even when access is possible, current tools lack the precision needed to deliver localized therapy without collateral damage. This creates a major gap between early detection and effective intervention — especially in narrow ducts, deep tissue, and sensitive organs.
There is a clear unmet need for technologies that enable precise, minimally invasive intervention earlier in the disease course.
Our Solution
Embio's catheter introduces a new pathway — a minimally invasive, precision-targeted solution designed to deliver targeted therapy directly within hard-to-reach anatomical pathways.
Using standard endoscopic or stereotactic access, the catheter can be positioned accurately at the treatment site and activated to deliver controlled electrical pulses or electrochemical therapy with high spatial precision, allowing earlier, gentler intervention compared to conventional treatments.
This approach enables earlier, localized, and less invasive treatment options across multiple indications where conventional tools fall short.
Animation of our catheter
Ultra-thin Design
Allows access to delicate tissue and even the narrowest ducts safely and efficiently
Customisable Electrodes
Allows flexible spacing and configurations, and high-density electrode design for precise energy delivery
Unique Patent-pending Mechanism
Provides stable tissue contact and controlled field geometry, essential for reduced shunting and heating
Dual Therapy Capability (IRE & ECT)
Supports both irreversible electroporation and electrochemical therapy, enabling ablation or drug-enhanced therapy
Our Products
One Platform. Multiple Indications.
Embio’s modular catheter platform enables dense electrode architectures for specific anatomical clinical use-cases.
DuCath™
Intraductal Electroporation Catheter
- Ultra-thin catheter engineered for safe navigation through fragile duct anatomy
- Dense ring electrode layout
- Enables precise electroporation directly at the disease site
- Designed to integrate seamlessly into existing endoscopic workflows
Primary focus: Pancreatic & bile duct cancers
PenCath™
Penetrating Duct-Wall Electroporation Catheter
- Enables targeted treatment of tumours located adjacent to, but not inside the duct lumen
- Allows localised treatment while preserving critical nearby structures
- Designed for highly constrained anatomical environments
- Addresses limitations of conventional ablation technologies
Primary focus: Pancreatic and bile duct tumours that are inaccessible from within the lumen alone
PonCath™
Pediatric Brainstem Tumor Electroporation Catheter
- Next-generation, ultra-thin stereotactic probe concept for treating highly sensitive neural structures
- Designed for extreme precision in delicate brain anatomy
- Enables electroporation where surgery and thermal ablation are not viable
Primary focus: Pediatric brainstem tumours, including diffuse intrinsic pontine glioma (DIPG) (concept)